Personalised nutrition: Ready for practice?

Proceedings of the Nutrition Society

Volumn 72, Issue 1, 2013, Pages 48-52

  De Roos, Baukje ^a  

^a ROWETT RESEARCH INSTITUTE   (United Kingdom)

Author keywords

Dietary advice; Genetic testing; Nutrigenetics; Nutrigenomics; Personalised nutrition

Indexed keywords

APOLIPOPROTEIN E4; C REACTIVE PROTEIN; COMPLEMENT COMPONENT C3A; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OMEGA 3 FATTY ACID; PROTEIN; VITAMIN D;

ABDOMINAL OBESITY; BODY WEIGHT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL PRACTICE; CONFERENCE PAPER; CONSUMER; DIET; DIETARY INTAKE; ENVIRONMENTAL FACTOR; FOOD; FOOD INDUSTRY; GENE INTERACTION; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GLUCOSE BLOOD LEVEL; HEALTH CARE POLICY; HEALTH PROMOTION; HEREDITY; HUMAN; INFLAMMATION; INSULIN RESISTANCE; LACTASE DEFICIENCY; LACTOSE INTOLERANCE; LIFESTYLE MODIFICATION; LIPOPROTEIN METABOLISM; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRIGENOMICS; NUTRITION; OSTEOPOROSIS; PERSONALIZED NUTRITION; PHENOTYPE; PRIVACY; SINGLE NUCLEOTIDE POLYMORPHISM; SUPPLEMENTATION; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN;

DIET; ENVIRONMENT; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HEALTH; HUMANS; NUTRIGENOMICS; NUTRITIONAL PHYSIOLOGICAL PHENOMENA; PHENOTYPE; RISK FACTORS;

EID: 84872852666     PISSN: 00296651     EISSN: 14752719     Source Type: Journal    
DOI: 10.1017/S0029665112002844     Document Type: Conference Paper

References (31)

1. Department of Health (1991) Dietary reference values for food energy and nutrients for the United Kingdom. No. 41. London: The Stationery Office.
2. WHO (2009) Global Health Risks. Mortality and burden of disease attributable to selected major risks. Available at: http://www.who.int/ healthinfo/global-burden-disease/GlobalHealthRisks-report-full.pdf
3. Cooney MT, Dudina A, Whincup P et al. (2009) Re-evaluating the Rose approach: comparative benefits of the population and high-risk preventive strategies. Eur J Cardi-ovasc Prev Rehabil 16, 541-549.
4. Rose G (1985) Sick individuals and sick populations. Int J Epidemiol 14, 32-38. (Pubitemid 15109489)
5. Nizel AE (1972) Personalized nutrition counseling. ASDC J Dent Child 39, 353-360.
6. Minihane AM, Khan S, Leigh-Firbank EC et al. (2000) ApoE polymorphism and fish oil supplementation in subjects with an atherogenic lipoprotein phenotype. Arterioscler Thromb Vasc Biol 20, 1990-1997. (Pubitemid 30648814)
7. Minihane AM (2010) Fatty acid-genotype interactions and cardiovascular risk. Prostaglandins Leukot Essent Fatty Acids 82, 259-264.
8. Caslake MJ, Miles EA, Kofler BM et al. (2008) Effect of sex and genotype on cardiovascular biomarker response to fish oils: the FINGEN Study. Am J Clin Nutr 88, 618-629.
9. Madden J, Williams CM, Calder PC et al. (2011) The impact of common gene variants on the response of biomarkers of cardiovascular disease (CVD) risk to increased fish oil fatty acids intakes. Annu Rev Nutr 31, 203-234.
10. Olano-Martin E, Anil E, Caslake MJ et al. (2010) Contribution of apolipoprotein E genotype and docosahexaenoic acid to the LDL-cholesterol response to fish oil. Atherosclerosis 209, 104-110.
11. Bouchard C, Tremblay A, Despres JP et al. (1990) The response to long-term overfeeding in identical twins. N Engl J Med 322, 1477-1482. (Pubitemid 20179860)
12. Williams PT, Blanche PJ, Rawlings R et al. (2005) Concordant lipoprotein and weight responses to dietary fat change in identical twins with divergent exercise levels 1. Am J Clin Nutr 82, 181-187. (Pubitemid 41716391)
13. Hesketh J, Wybranska I, Dommels Y et al. (2006) Nutrient-gene interactions in benefit-risk analysis. Br J Nutr 95, 1232-1236. (Pubitemid 43986006)
14. Matthews SB, Waud JP, Roberts AG et al. (2005) Systemic lactose intolerance: a new perspective on an old problem. Postgrad Med J 81, 167-173. (Pubitemid 40387965)
15. Rimbach G & Minihane AM (2009) Nutrigenetics and personalised nutrition: how far have we progressed and are we likely to get there? Proc Nutr Soc 68, 162-172.
16. van Ommen B (2007) Personalized nutrition from a health perspective: luxury or necessity? Genes Nutr 2, 3-4.
17. Kaput J, Ordovas JM, Ferguson L et al. (2005) The case for strategic international alliances to harness nutritional genomics for public and personal health. Br J Nutr 94, 623-632. (Pubitemid 41672363)
18. O'Sullivan A, Gibney MJ, Connor AO et al. (2011) Biochemical and metabolomic phenotyping in the identification of a vitamin D responsive metabotype for markers of the metabolic syndrome. Mol Nutr Food Res 55, 679-690.
19. Phillips CM, Goumidi L, Bertrais S et al. (2009) Complement component 3 polymorphisms interact with poly-unsaturated fatty acids to modulate risk of metabolic syndrome. Am J Clin Nutr 90, 1665-1673.
20. Joost HG, Gibney MJ, Cashman KD et al. (2007) Personalised nutrition: status and perspectives. Br J Nutr 98, 26-31. (Pubitemid 47272143)
21. Curtis PJ, Adamson AJ & Mathers JC (2012) Effects on nutrient intake of a family-based intervention to promote increased consumption of low-fat starchy foods through education, cooking skills and personalised goal setting: the Family Food and Health Project. Br J Nutr 107, 1833-1844.
22. Bouwman LI & Koelen MA (2007) Communication on personalised nutrition: individual-environment interaction. Genes Nutr 2, 81-83.
23. Caulfield T, Ries NM, Ray PN et al. (2010) Direct-to-consumer genetic testing: good, bad or benign? Clin Genet 77, 101-105.
24. Nuffield Council on Bioethics (2010) Medical Profiling and Online Medicine: The Ethics of 'Personalised Healthcare' in a Consumer Age. Available at: http://www.nuffieldbioethics.org/sites/default/files/Medical
25. Tamir S (2010) Direct-to-consumer genetic testing: ethical-legal perspectives and practical considerations. Med Law Rev 18, 213-238.
26. Department of Health (2004) Choosing Health: Making Healthy Choices Easier. Public Health White Paper. Available at: http://webarchive. nationalarchives.gov.uk/+/www.dh. gov.uk/en/Publicationsandstatistics/ Publications/Publications PolicyAndGuidance/DH-4094559)
27. Phillips CM, Goumidi L, Bertrais S et al. (2010) Additive effect of polymorphisms in the IL-6, LTA, and TNF-{alpha} genes and plasma fatty acid level modulate risk for the metabolic syndrome and its components. J Clin Endocrinol Metab 95, 1386-1394.
28. Ferguson JF, Phillips CM, Tierney AC et al. (2010) Gene-nutrient interactions in the metabolic syndrome: single nucleotide polymorphisms in ADIPOQ and ADIPOR1 interact with plasma saturated fatty acids to modulate insulin resistance. Am J Clin Nutr 91, 794-801.
29. Stewart-Knox BJ, Bunting BP, Gilpin S et al. (2009) Attitudes toward genetic testing and personalised nutrition in a representative sample of European consumers. Br J Nutr 101, 982-989.
30. Ronteltap A, van Trijp JC & Renes RJ (2009) Consumer acceptance of nutrigenomics-based personalised nutrition. Br J Nutr 101, 132-144. (Pubitemid 352795592)
31. Ronteltap A, van Trijp JC, Renes RJ et al. (2007) Consumer acceptance of technology-based food innovations: lessons for the future of nutrigenomics. Appetite 49, 1-17. (Pubitemid 46754537)